MetaVia Statistics
NASDAQ: MTVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.45-0.0098 (-0.67%)
Market open · Delayed 15 min · as of Oct 8, 11:07 AM ET
MetaVia by the numbers
MetaVia has a market capitalization of $9.6 million based on 6.59M shares outstanding. With trailing EPS of $-3.65, MetaVia is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.2% below its 50-day average and 36.8% below its 200-day average.
Average daily trading volume is 230.88K shares, or about $334,816 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MTVA valuation vs. peer median
| Metric | MTVA | Peer median | Difference |
|---|---|---|---|
| Market cap | $9.55M | $9.83M | -3% |
| Avg. volume | 230.88K | 1.26M | -82% |
Peer median across 8 companies: CALC, CMMB, IMRN, ADIL, VTGN, APUS, TOVX, JAGX.
Valuation
- Market cap
- $9.55M
- EPS (TTM)
- $-3.65
- Shares outstanding
- 6.59M
Price and trading
- Previous close
- 1.46
- Open
- 1.47
- Day range
- 1.45 – 1.48
- 52-week range
- 0.966 – 14.85
- Beta
- —
- Volume
- 14.63K
- Average volume
- 230.88K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 9.55M
- Eps
- -3.65
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.85
- Week52 Low
- 0.97
- Avg Volume
- 230.88K
- Shares Outstanding
- 6.59M
- Ma50
- 1.58
- Ma200
- 2.30
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -90.23%
- Pct From52w Low
- 50.12%